Stay updated on ARO-RAGE in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the ARO-RAGE in Healthy Subjects Clinical Trial page.

Latest updates to the ARO-RAGE in Healthy Subjects Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record presents details of Arrowhead Pharmaceuticals’ completed Phase 1 ARO-RAGE study in healthy volunteers, including its eligibility criteria, study design, interventions, and safety and pharmacokinetic outcomes.SummaryDifference41%

- Check22 days agoChange DetectedThe footer's site revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH website updates and says that some federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check36 days agoChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to ARO-RAGE in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-RAGE in Healthy Subjects Clinical Trial page.